☆ 4.6 Article

COVID-19 Modulates Inflammatory and Renal Markers That May Predict Hospital Outcomes among African American Males

VIRUSES-BASEL (2021)

Related references

Note: Only part of the references are listed.

Review Virology

Covid-19 and kidney injury: Pathophysiology and molecular mechanisms

Elham Ahmadian et al.

Summary: Kidney involvement in Covid-19 mainly presents as proteinuria and acute kidney injury, with mechanisms including direct viral infection of kidney cells, immune dysregulation, and other factors. Understanding the pathophysiology is crucial for developing effective therapeutic strategies.

REVIEWS IN MEDICAL VIROLOGY (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Prognostic value of interleukin-18 and its association with other inflammatory markers and disease severity in COVID-19

Hasan Satis et al.

Summary: This study investigated the association of IL-18 with other inflammatory markers in COVID-19 patients, finding that serum IL-18 levels correlate with disease severity and higher levels are associated with worse outcomes.

CYTOKINE (2021)

Add to Collection

Article Multidisciplinary Sciences

Reductions in 2020 US life expectancy due to COVID-19 and the disproportionate impact on the Black and Latino populations

Theresa Andrasfay et al.

Summary: The COVID-19 pandemic has significantly reduced life expectancy in the United States, particularly impacting Black and Latino populations. Projections suggest a stark decline in life expectancy for these groups compared to Whites, with significant implications for health disparities.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)

Add to Collection

Article Medicine, Research & Experimental

An immune-based biomarker signature is associated with mortality in COVID-19 patients

Michael S. Abers et al.

Summary: Immune and inflammatory responses are important factors contributing to disease severity in COVID-19. This study identified specific immune-based biomarkers associated with mortality in COVID-19 patients, with some biomarkers consistently higher in those who died compared to those who recovered, suggesting their potential for early prediction of disease outcome.

JCI INSIGHT (2021)

Add to Collection

Article Medicine, General & Internal

Racial Disparities in COVID-19 Testing and Outcomes Retrospective Cohort Study in an Integrated Health System

Gabriel J. Escobar et al.

Summary: Racial disparities exist in outcomes after SARS-CoV-2 infection, with race being the most important predictor of infection and associated with increased hospitalization risk but not mortality. Adjusted analyses showed no racial differences in inpatient mortality or total mortality during the study period.

ANNALS OF INTERNAL MEDICINE (2021)

Add to Collection

Article Health Care Sciences & Services

Impact of Race and Socioeconomic Status on Outcomes in Patients Hospitalized with COVID-19

Daniel Quan et al.

Summary: Racial and socioeconomic disparities impact clinical outcomes for COVID-19 patients, with higher neighborhood income associated with lower rates of IMV and ICU admission. Policies targeting neighborhood disadvantage may help mitigate COVID-19 disparities in the Black community.

JOURNAL OF GENERAL INTERNAL MEDICINE (2021)

Add to Collection

Article Multidisciplinary Sciences

Exposure and risk factors for COVID-19 and the impact of staying home on Michigan residents

Kuan-Han H. Wu et al.

Summary: COVID-19 has had a significant impact on clinical care and lifestyles globally, with a substantial number of cases reported in the State of Michigan. African Americans were found to have higher rates of COVID-19 diagnosis, which may be attributed to factors such as working as essential workers and lower socioeconomic status. Efforts should be made to focus on prevention and mitigation strategies for COVID-19 and address the existing inequality gaps that contribute to higher risks for certain populations.

PLOS ONE (2021)

Add to Collection

Article Multidisciplinary Sciences

Rapid seroconversion and persistent functional IgG antibodies in severe COVID-19 patients correlates with an IL-12p70 and IL-33 signature

Ariel Munitz et al.

Summary: The study found that moderate/severe patients rapidly developed IgG/IgA antibodies, while IgM antibodies against the viral receptor binding domain were detected early in the disease. There was a significant reduction in IgM/IgA antibodies over time. The presence of potentially neutralizing antibodies was correlated with IgG/IgA levels.

SCIENTIFIC REPORTS (2021)

Add to Collection

Article Public, Environmental & Occupational Health

Visualizing COVID-19 Mortality Rates and African-American Populations in the USA and Pennsylvania

Beverly I. Anaele et al.

Summary: The Centers for Disease Control and Prevention have identified African-Americans as having an increased risk of COVID-19 mortality, with disparities rooted in healthcare access and social determinants of health. Research found that areas with higher African-American populations generally had higher COVID-19 mortality rates, particularly in the northeast USA and eastern PA. These relationships were quantified through statistical analyses at both state and county levels, highlighting the need for more resources to address the high COVID-19 mortality rates among African-American populations.

JOURNAL OF RACIAL AND ETHNIC HEALTH DISPARITIES (2021)

Add to Collection

Review Public, Environmental & Occupational Health

Association Between Ethnicity and Severe COVID-19 Disease: a Systematic Review and Meta-analysis

Antony Raharja et al.

Summary: This study found that compared to White ethnicity, Black and Asian populations had similar overall mortality rates, while Hispanic ethnicity had lower overall mortality rates. After adjusting for age, sex, and comorbidities, the elevated risks for Black and Asian populations became non-significant. There was a trend towards greater disparities in COVID-19 outcomes for ethnic minorities in the UK.

JOURNAL OF RACIAL AND ETHNIC HEALTH DISPARITIES (2021)

Add to Collection

Article Hematology

Hemoperfusion with CytoSorb as Adjuvant Therapy in Critically Ill Patients with SARS-CoV2 Pneumonia

Teresa Rampino et al.

Summary: Preliminary experience with Hemoperfusion (HP) as adjuvant therapy in COVID-19 patients showed potential efficacy, with better clinical outcomes in treated patients compared to control group. However, further randomized clinical trials are needed to confirm these findings.

BLOOD PURIFICATION (2021)

Add to Collection

Review Immunology

Should we stimulate or suppress immune responses in COVID-19? Cytokine and anti-cytokine interventions

Yvan Jamilloux et al.

AUTOIMMUNITY REVIEWS (2020)

Add to Collection

Article Medicine, General & Internal

Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy

Giacomo Grasselli et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

Add to Collection

Editorial Material Cardiac & Cardiovascular Systems

COVID-19 illness in native and immunosuppressed states: A clinical?therapeutic staging proposal

Hasan K. Siddiqi et al.

JOURNAL OF HEART AND LUNG TRANSPLANTATION (2020)

Add to Collection

Article Urology & Nephrology

Kidney disease is associated with in-hospital death of patients with COVID-19

Yichun Cheng et al.

KIDNEY INTERNATIONAL (2020)

Add to Collection

Article Medicine, General & Internal

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

Fei Zhou et al.

LANCET (2020)

Add to Collection

Article Rheumatology

On the Alert for Cytokine Storm: Immunopathology in COVID-19

Lauren A. Henderson et al.

ARTHRITIS & RHEUMATOLOGY (2020)

Add to Collection

Article Medicine, General & Internal

Hospitalization and Mortality among Black Patients and White Patients with Covid-19

Eboni G. Price-Haywood et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Add to Collection

Article Allergy

IL-6-based mortality risk model for hospitalized patients with COVID-19

Rocio Laguna-Goya et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2020)

Add to Collection

Article Medicine, Research & Experimental

Clinical and pathological investigation of patients with severe COVID-19

Shaohua Li et al.

JCI INSIGHT (2020)

Add to Collection

Article Medicine, General & Internal

Clinical Characteristics and Morbidity Associated With Coronavirus Disease 2019 in a Series of Patients in Metropolitan Detroit

Geehan Suleyman et al.

JAMA NETWORK OPEN (2020)

Add to Collection

Review Infectious Diseases

Clinical characteristics of coronavirus disease 2019 (COVID-19) in China: A systematic review and meta-analysis

Leiwen Fu et al.

JOURNAL OF INFECTION (2020)

Add to Collection

Article Immunology

Serum Cytokine and Chemokine Profile in Relation to the Severity of Coronavirus Disease 2019 in China

Ying Chi et al.

JOURNAL OF INFECTIOUS DISEASES (2020)

Add to Collection

Article Critical Care Medicine

Uncontrolled Innate and Impaired Adaptive Immune Responses in Patients with COVID-19 Acute Respiratory Distress Syndrome

Sophie Hue et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2020)

Add to Collection

Letter Medical Laboratory Technology

An evidence for correlation between the glutathione S-transferase T1 (GSTT1) polymorphism and outcome of COVID-19

Mostafa Saadat

CLINICA CHIMICA ACTA (2020)

Add to Collection

Article Medicine, General & Internal

Efficacy of Tocilizumab in Patients Hospitalized with Covid-19

John H. Stone et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Add to Collection

Article Multidisciplinary Sciences

Severe acute kidney injury in COVID-19 patients is associated with in-hospital mortality

Jin Hyuk Paek et al.

PLOS ONE (2020)

Add to Collection

Article Multidisciplinary Sciences

Increased interleukin-6 and macrophage chemoattractant protein-1 are associated with respiratory failure in COVID-19

Marthe Jontvedt Jorgensen et al.

SCIENTIFIC REPORTS (2020)

Add to Collection

Article Respiratory System

Inflammatory phenotyping predicts clinical outcome in COVID-19

H. Burke et al.

RESPIRATORY RESEARCH (2020)

Add to Collection

Article Rheumatology

Anakinra for severe forms of COVID-19: a cohort study

Thomas Huet et al.

LANCET RHEUMATOLOGY (2020)

Add to Collection

Letter Biochemistry & Molecular Biology

Temporal profiling of plasma cytokines, chemokines and growth factors from mild, severe and fatal COVID-19 patients

Zhi-Sheng Xu et al.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)

Add to Collection

Review Medicine, General & Internal

Acute Renal Failure in Critically Ill COVID19 Patients With a Focus on the Role of Renal Replacement Therapy: A Review of What We Know So Far

Ahmad Raza et al.

CUREUS JOURNAL OF MEDICAL SCIENCE (2020)

Add to Collection

Review Medicine, General & Internal

The impact of ethnicity on clinical outcomes in COVID-19: A systematic review

Daniel Pan et al.

ECLINICALMEDICINE (2020)

Add to Collection

Review Immunology

How COVID-19 induces cytokine storm with high mortality

Shintaro Hojyo et al.

INFLAMMATION AND REGENERATION (2020)

Add to Collection

Review Biochemistry & Molecular Biology

Relevance of the deletion polymorphisms of the glutathione S-transferases GSTT1 and GSTM1 in pharmacology and toxicology

H. M. Bolt et al.

CURRENT DRUG METABOLISM (2006)

Add to Collection

© Peeref 2019-2024. All rights reserved.